BROWN RUDNICK LLP for APOTEX CORPORATION
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Report (this page) | Jan 20, 2018 | $50,000 | Replaced |
| 4th Quarter - Amendment | Jan 20, 2018 | $50,000 | Yes |
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
Issues relating to inter parte review challenges.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA LAYMAN | SPA, Sen. Stabenow (05-07); SPA, Sen Graham(01-04); LA, Sen Bryan(00); LA, Sen Chafee(97-99); CBO, PA(92-96) |
| HENRY W MENN | CoS, Sen. Bob Graham (01 - 04); Min SD & Counsel, Cmte on Vet Affairs (04); Sp Asst Leg Aff, FDA Off of Commission (93-95) |
Health Issues HCR
HCR: H.R. 2430 & S. 934-FDA Reauthorization Act of 2017; H.R. 2051-Fair Access for Safe and Timely Generics Act of 2017; H.R. 2212 & S. 974, the Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA LAYMAN | SPA, Sen. Stabenow (05-07); SPA, Sen Graham(01-04); LA, Sen Bryan(00); LA, Sen Chafee(97-99); CBO, PA(92-96) |
| HENRY W MENN | CoS, Sen. Bob Graham (01 - 04); Min SD & Counsel, Cmte on Vet Affairs (04); Sp Asst Leg Aff, FDA Off of Commission (93-95) |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.